1132 



SUBJECT INDEX 



Alkylmalonates, succinate dehydrogen- 

 ase, 37-38, 40 

 Alkylnormorphines, morphine iV-deme- 



thylase, 590, 604 

 AlHinase (alHin lyase), o-iodosobenzoate, 



706 

 Alhin lyase, see Alliinase 

 Allohydroxy - d - proline oxidase, quina- 



crine, 547, 549 

 Allomyces macrogynus, 



respiration (endogenous), malonate, 168 



succinate dehydrogenase, malonate, 27 

 Allopurinol (Zyloprim), 



urinary excretion of xanthines, 283 



xanthine oxidase, 283 

 Allose, fructokinase, 376-377 

 Allose kinase, mercurials, 833 

 Allose-6-phosphate, 



hexokinase, 379-380 



structure of. 378 

 Allothreonine aldolase, o-iodosobenzoate, 



706 

 Alloxazine, L-amino acid oxidase, 541 

 Allylglycine, DL-methionine uptake by 



ascites cells, 265 

 iV^-Allylnormorphine, see Nalorphine 

 Alternaria solani, growth of, 



dehydroacetate, 633 

 Altrose, fructokinase, 376 

 Altrose-6-phosphate, hexokinase, 380 

 Ameboid movement, mercurials, 982 

 Amethopterin (Methotrexate), 



acetyl transfer in liver, 586 



dihydro folate reductase, 581-584 



folate deficiency, 581 



formate incorporation into proteins, 585 



purine biosynthesis, 585 



resistance to, 583 



structure of, 580 



sulfonamide acetylation, 586 



tetrahydrofolate biosynthesis, 581 



tissue distribution, 583 

 Amidines, 



diamine oxidase, 360-365 



structures of, 361 

 Amidophosphoribosyltransferase, see 



Phosphoribosylpyrophosphate amido- 



transferase 



Amidosulfonate, see Sulfamate 



Amine oxidase, see Monoamine oxidase 



Aminoacetone synthetase, ferricyanide, 



674 

 Amino acid activating enzymes, see spe- 

 cific L-amino acid:sRNA ligases 

 Amino acid decarboxylase, see also spe- 

 cific enzymes 

 analogs, 317 

 mercurials, 780 



protection by pyridoxal-P, 780 



protection by substrates, 780 

 a-methyl-w -tyrosine in vivo, 315-317 

 permanganate, 660 

 D-Amino acid oxidase, 

 adenine analogs, 545 

 amino acid analogs, 340-348 

 analogs, 347-348, 545 



competition with FAD, 347-348 



competition with substrates, 347- 



348 



FAD complexes, 347-348 

 benzoates, 341-348 

 o-iodosobenzoate, 704, 706, 717-718 



protection by FAD, 717 



protection by substrates, 717 



reversal by cysteine, 718 

 kojic acid, 349-350 

 maleate, 343 

 malonate, 60 

 mercurials, 780, 804 



protection by alanine, 780 



protection by FAD, 780 



relation to SH groups, 804 

 p-mercuribenzoate, competitive nature 

 of inhibition, 771-772 

 nucleotides, 545 

 quinacrine, 547, 549, 557, 560 

 riboflavin analogs, 540-541, 544 

 L-Amino acid oxidase, 

 analogs, 338-340 



pH effects, 340 

 benzoate, 348 

 D-leucine, 268 

 malonate, 60 

 D-phenylalanine, 268 

 quinacrine, 547, 549 

 riboflavin analogs, 540-542 



